Form 4 for KRYS Krystal Biotech, Inc.
Accepted 2022-11-10 00:00:00 ET · period of report 2022-11-08 · accession 0001298711-22-000007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-11-10 | 2022-11-08 | KRYS | Krishnan Suma | Pres, R, D, Dir, 10% | S - Sale | $80.04 | -823 | 1.73M | -0.0% | -$65.9K | |
| I | 2022-11-10 | 2022-11-08 | KRYS | Krishnan Suma | Pres, R, D, Dir, 10% | S - Sale | $80.05 | -966 | 1.79M | -0.1% | -$77.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-08 | S | D | 823 | $80.04 | 1,726,440 | D By Spouse | — | — | (F2) The transaction was executed in multiple trades ranging from $80.0000 to $80.1900. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. (F5) Directly beneficially owned by Krish S. Krishnan, the spouse of the Reporting Person. |
| 2 | Common | Common Stock | 2022-11-08 | S | D | 966 | $80.05 | 1,787,722 | I | — | — | (F4) These same shares are also being reported on a Form 4 by the Reporting Person's spouse, Krish Krishnan. (F2) The transaction was executed in multiple trades ranging from $80.0000 to $80.1900. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. |